Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Impulse control disorders in Parkinson's disease
Valerie Voon, Arpan R. Mehta, Mark Hallett
Current Opinion in Neurology (2011) Vol. 24, Iss. 4, pp. 324-330
Open Access | Times Cited: 178

Showing 1-25 of 178 citing articles:

Parkinson disease
Werner Poewe, Klaus Seppi, Caroline M. Tanner, et al.
Nature Reviews Disease Primers (2017) Vol. 3, Iss. 1
Closed Access | Times Cited: 3852
Neurocognitive endophenotypes of impulsivity and compulsivity: towards dimensional psychiatry
Trevor W. Robbins, Claire M. Gillan, Dana Smith, et al.
Trends in Cognitive Sciences (2011) Vol. 16, Iss. 1, pp. 81-91
Closed Access | Times Cited: 954
Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease
Matthieu F. Bastide, Wassilios G. Meissner, Barbara Picconi, et al.
Progress in Neurobiology (2015) Vol. 132, pp. 96-168
Open Access | Times Cited: 431
The neurobiological basis of cognitive impairment in Parkinson's disease
Glenda M. Halliday, James B. Leverenz, Jay S. Schneider, et al.
Movement Disorders (2014) Vol. 29, Iss. 5, pp. 634-650
Open Access | Times Cited: 329
Subthalamic stimulation in Parkinson’s disease: restoring the balance of motivated behaviours
Eugénie Lhommée, Hélène Klinger, Stéphane Thobois, et al.
Brain (2012) Vol. 135, Iss. 5, pp. 1463-1477
Open Access | Times Cited: 283
The influence of age and gender on motor and non-motor features of early Parkinson's disease: Initial findings from the Oxford Parkinson Disease Center (OPDC) discovery cohort
Konrad Szewczyk‐Królikowski, Paul Tomlinson, Kannan Nithi, et al.
Parkinsonism & Related Disorders (2013) Vol. 20, Iss. 1, pp. 99-105
Open Access | Times Cited: 260
Reconceptualizing anhedonia: novel perspectives on balancing the pleasure networks in the human brain
Kristine Rømer Thomsen, Peter C. Whybrow, Morten L. Kringelbach
Frontiers in Behavioral Neuroscience (2015) Vol. 9
Open Access | Times Cited: 220
Signaling pathways in Parkinson’s disease: molecular mechanisms and therapeutic interventions
Dong-Chen Xu, Yong Chen, Yang Xu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 207
Selective dysfunction of basal ganglia subterritories: From movement to behavioral disorders
Léon Tremblay, Yulia Worbe, Stéphane Thobois, et al.
Movement Disorders (2015) Vol. 30, Iss. 9, pp. 1155-1170
Closed Access | Times Cited: 199
New experimental and clinical links between the hippocampus and the dopaminergic system in Parkinson's disease
Paolo Calabresi, Anna Castrioto, Massimiliano Di Filippo, et al.
The Lancet Neurology (2013) Vol. 12, Iss. 8, pp. 811-821
Closed Access | Times Cited: 199
Imbalance in the sensitivity to different types of rewards in pathological gambling
Guillaume Sescousse, Guillaume Barbalat, Philippe Domenech, et al.
Brain (2013) Vol. 136, Iss. 8, pp. 2527-2538
Open Access | Times Cited: 175
Parkinson’s disease as a system-level disorder
Daniele Caligiore, Rick C. Helmich, Mark Hallett, et al.
npj Parkinson s Disease (2016) Vol. 2, Iss. 1
Open Access | Times Cited: 147
Behavioural outcomes of subthalamic stimulation and medical therapy versus medical therapy alone for Parkinson's disease with early motor complications (EARLYSTIM trial): secondary analysis of an open-label randomised trial
Eugénie Lhommée, Lars Wojtecki, Virginie Czernecki, et al.
The Lancet Neurology (2018) Vol. 17, Iss. 3, pp. 223-231
Closed Access | Times Cited: 132
Advances in Parkinson’s Disease: 200 Years Later
Natalia López‐González del Rey, Ana Quiroga‐Varela, Elisa Garbayo, et al.
Frontiers in Neuroanatomy (2018) Vol. 12
Open Access | Times Cited: 130
Extrastriatal dopaminergic abnormalities of DA homeostasis in Parkinson's patients with medication-induced pathological gambling: A [11C] FLB-457 and PET study
Nicola Ray, Janis M. Miyasaki, Mateusz Zurowski, et al.
Neurobiology of Disease (2012) Vol. 48, Iss. 3, pp. 519-525
Open Access | Times Cited: 128
Multiple Modes of Impulsivity in Parkinson's Disease
Cristina Nombela, Timothy Rittman, Trevor W. Robbins, et al.
PLoS ONE (2014) Vol. 9, Iss. 1, pp. e85747-e85747
Open Access | Times Cited: 127
A Systematic Review of Impulse Control Disorders in Parkinson's Disease
Mette Buhl Callesen, Jørgen Scheel‐Krüger, Morten L. Kringelbach, et al.
Journal of Parkinson s Disease (2013) Vol. 3, Iss. 2, pp. 105-138
Open Access | Times Cited: 125
Nonmotor Symptoms in Parkinson’s Disease in 2012: Relevant Clinical Aspects
A. M. Bonnet, Marie France Jutras, Virginie Czernecki, et al.
Parkinson s Disease (2012) Vol. 2012, pp. 1-15
Open Access | Times Cited: 117
Selective serotonin reuptake inhibition modulates response inhibition in Parkinson’s disease
Zheng Ye, Ellemarije Altena, Cristina Nombela, et al.
Brain (2014) Vol. 137, Iss. 4, pp. 1145-1155
Open Access | Times Cited: 116
Unmasking levodopa resistance in Parkinson's disease
Jorik Nonnekes, Monique H.M. Timmer, Nienke M. de Vries, et al.
Movement Disorders (2016) Vol. 31, Iss. 11, pp. 1602-1609
Closed Access | Times Cited: 106
Strategies for the Treatment of Parkinson’s Disease: Beyond Dopamine
Alexandre Iarkov, George E. Barreto, J. Alex Grizzell, et al.
Frontiers in Aging Neuroscience (2020) Vol. 12
Open Access | Times Cited: 103
Alpha-Synuclein Produces Early Behavioral Alterations via Striatal Cholinergic Synaptic Dysfunction by Interacting With GluN2D N -Methyl-D-Aspartate Receptor Subunit
Alessandro Tozzi, Antonio de Iure, Vincenza Bagetta, et al.
Biological Psychiatry (2015) Vol. 79, Iss. 5, pp. 402-414
Closed Access | Times Cited: 100
Molecular, Neurochemical, and Behavioral Hallmarks of Reserpine as a Model for Parkinson's Disease: New Perspectives to a Long‐Standing Model
Anderson H.F.F. Leão, Aldair J. Sarmento‐Silva, José R. Santos, et al.
Brain Pathology (2015) Vol. 25, Iss. 4, pp. 377-390
Open Access | Times Cited: 94
Emotional manifestations of PD: Neurobiological basis
Anna Castrioto, Stéphane Thobois, Sébastien Carnicella, et al.
Movement Disorders (2016) Vol. 31, Iss. 8, pp. 1103-1113
Open Access | Times Cited: 94
Parkinson Disease: An Update
Steven J. Frucht
The Neurologist (2004) Vol. 10, Iss. 4, pp. 185-194
Open Access | Times Cited: 133
Page 1 - Next Page

Scroll to top